| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Careers Employment > Career and Employment; Buying a Franchise Means Disclosing Financial Information? |
|
Advice You - Career and Employment; Buying a Franchise Means Disclosing Financial Information?
If you choose a career option such as buying your own franchise rather than taking a job in Corporate America you mu According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product st realize that you will have to disclose certain financial information in order to qualify prior to the sales proce ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s or acceptance of application. Some believe this is not fair and worry about identity theft. So, should the governm lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ent regulators allow franchisors to ask for this information? Some franchise buyers say no and yet how can the fran here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe hisor know if you have the money to purchase the franchise in the first place? Now then your financial information i d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s necessary because 80% of all franchise applicants lie about their financial ability to buy a franchise and this co ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ts franchisors money in wasted effort from sales staff. Meaning 80% of their time would be burned up if in fact they easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi coddled all the liars out there. This means 80% of the cost is added to the ratio of franchise fees to sales. Gener nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically lly if my memory holds true the average franchisor uses up some 50% in the sales process. If you add 80% more then y and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ou would have to raise the franchise fee by 120% just to break even and 240% to hold the same 50% ratio. Meaning a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ranchise fee of $20,000 would have to be some $46,000 and then less people could afford it and would all be charged ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ore money and thus hurt the consumer? See how the logic hurts consumers? So what those who decry the surrender of su dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ch information they want more rules on franchisors to protect franchisees who do not tell the truth? Why not reduce cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin he rules and deregulate and lower the costs for everyone, meaning your investment might be half and your business mi tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ght have succeeded? Everything is ass-backwards in franchise law. Could I do better? Of course, I have lived all sid t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s of the game, studied it from every angle, of course I could do better! But one has to ask why beat your head again ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust st the wall? I have been a franchisor, started my business with a single unit from scratch and been a Board of Dire y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products tor for the AAFD or American Association of Franchisees and Dealers. We need less rules and regulations on franchisi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ng. If franchise buyers do not wish to show their financial information to the franchisor then do not, you can alway elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip work in Corporate America or start your own business and learn the hard way from scratch. Consider all this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Forming a Nevada Corporation Gives You Protection Accounts Receivable Management How To Increase Your Profit Online Using Adwords
|